- Home
- Publications
- Publication Search
- Publication Details
Title
Chemically Programmable and Switchable CAR‐T Therapy
Authors
Keywords
-
Journal
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-04-24
DOI
10.1002/anie.202005432
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combining the best of two worlds: Highly flexible chimeric antigen receptor adaptor molecules (CAR-adaptors) for the recruitment of chimeric antigen receptor T cells
- (2019) Diana Darowski et al. mAbs
- Target 2035: probing the human proteome
- (2019) Adrian J. Carter et al. DRUG DISCOVERY TODAY
- Regulation of CAR T cell-mediated cytokine release syndrome-like toxicity using low molecular weight adapters
- (2019) Yong Gu Lee et al. Nature Communications
- A probe for every protein
- (2019) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Conventional and Chemically Programmed Asymmetric Bispecific Antibodies Targeting Folate Receptor 1
- (2019) Junpeng Qi et al. Frontiers in Immunology
- Site-Specific Lysine Arylation as an Alternative Bioconjugation Strategy for Chemically Programmed Antibodies and Antibody–Drug Conjugates
- (2019) Dobeen Hwang et al. BIOCONJUGATE CHEMISTRY
- Translating anti-CD19 CAR T-Cell therapy into clinical practice for relapsed/refractory diffuse large B-Cell lymphoma
- (2018) Victor A. Chow et al. BLOOD
- CAR T Cells in Trials: Recent Achievements and Challenges that Remain in the Production of Modified T Cells for Clinical Applications
- (2018) Ulrike Köhl et al. HUMAN GENE THERAPY
- Chemical probes and drug leads from advances in synthetic planning and methodology
- (2018) Christopher J. Gerry et al. NATURE REVIEWS DRUG DISCOVERY
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- Advances in targeting the folate receptor in the treatment/imaging of cancers
- (2018) Marcos Fernández et al. Chemical Science
- CARs versus BiTEs: A Comparison between T Cell–Redirection Strategies for Cancer Treatment
- (2018) Clare Y. Slaney et al. Cancer Discovery
- Use of a Single CAR T Cell and Several Bispecific Adapters Facilitates Eradication of Multiple Antigenically Different Solid Tumors
- (2018) Yong Gu Lee et al. CANCER RESEARCH
- FDA Approval Summary: Tisagenlecleucel for Treatment of Patients with Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia
- (2018) Maura C. O’Leary et al. CLINICAL CANCER RESEARCH
- FDA Approval Summary: Axicabtagene Ciloleucel for Relapsed or Refractory Large B-cell Lymphoma
- (2018) Najat Bouchkouj et al. CLINICAL CANCER RESEARCH
- The in silico human surfaceome
- (2018) Damaris Bausch-Fluck et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Switchable control over in vivo CAR T expansion, B cell depletion, and induction of memory
- (2018) Sophie Viaud et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Therapeutic T cell engineering
- (2017) Michel Sadelain et al. NATURE
- Design of Switchable Chimeric Antigen Receptor T Cells Targeting Breast Cancer
- (2016) Yu Cao et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Chemically Programmed Bispecific Antibodies in Diabody Format
- (2016) Even Walseng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- DNA-encoded chemistry: enabling the deeper sampling of chemical space
- (2016) Robert A. Goodnow et al. NATURE REVIEWS DRUG DISCOVERY
- Versatile strategy for controlling the specificity and activity of engineered T cells
- (2016) Jennifer S. Y. Ma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Switch-mediated activation and retargeting of CAR-T cells for B-cell malignancies
- (2016) David T. Rodgers et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17
- (2016) Quirijn R.J.G. Tummers et al. Oncotarget
- Redirection of Genetically Engineered CAR-T Cells Using Bifunctional Small Molecules
- (2015) Min Soo Kim et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- How to minimalize antibodies
- (2015) Christoph Rader NATURE
- A Mass Spectrometric-Derived Cell Surface Protein Atlas
- (2015) Damaris Bausch-Fluck et al. PLoS One
- Chemically programmed antibodies
- (2014) Christoph Rader TRENDS IN BIOTECHNOLOGY
- The Nonsignaling Extracellular Spacer Domain of Chimeric Antigen Receptors Is Decisive for In Vivo Antitumor Activity
- (2014) M. Hudecek et al. Cancer Immunology Research
- Chemically Programmed Bispecific Antibodies That Recruit and Activate T Cells
- (2012) Huiting Cui et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells
- (2011) X. Wang et al. BLOOD
- In Vivo Persistence, Tumor Localization, and Antitumor Activity of CAR-Engineered T Cells Is Enhanced by Costimulatory Signaling through CD137 (4-1BB)
- (2011) D.-G. Song et al. CANCER RESEARCH
- Folate-Targeted Therapies for Cancer
- (2010) Wei Xia et al. JOURNAL OF MEDICINAL CHEMISTRY
- β-Lactam-based approach for the chemical programming of aldolase antibody 38C2
- (2009) Julia I. Gavrilyuk et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Impact of High and Low Folate Diets on Tissue Folate Receptor Levels and Antitumor Responses Toward Folate-Drug Conjugates
- (2008) C. P. Leamon et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search